Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, February 22, 2019
Assessing and mitigating risks is at the heart of everything we do across our vast portfolio.
read more
Thursday, December 27, 2018
The day before a planned Georgia General Assembly House study committee meeting, the Kratom Trade Association said it is reaching out to state lawmakers to directly resolve their concerns about kratom.
read more
Monday, December 17, 2018
Staten Biotechnology and Novo Nordisk have entered into a collaboration and exclusive option agreement to develop novel therapeutics for the treatment of hypertriglyceridaemia.
read more
Tuesday, January 05, 2021
Stäubli has announced a new Chief Executive Officer.
read more
Wednesday, February 25, 2026
SteinCares and Shilpa Biologicals announced a strategic licensing agreement to commercialize a biosimilar across Latin America.
read more
Wednesday, November 18, 2020
Stelis BioSource has started the next phase of its continued investment program.
read more
Wednesday, December 09, 2020
Stelis BioSource has started the next phase of its continued investment program after having already invested well over $100m into its facilities in Bangalore, India.
read more
Stellar Biotechnologies announced that third-party trial results have demonstrated that the company's KLH manufacturing methods achieve robust viral clearance.
read more
Stellar Biotechnologies initiated the second phase of an expansion project at the Port of Hueneme, north of Los Angeles.
read more
Thursday, August 10, 2017
Stellar Biotechnologies reported financial results for the three and nine months ended June 30, 2017 and provided an update on its business.
read more
Wednesday, January 02, 2019
Stem Cell Medicine has licensed an exosomes based technology for the treatment of neurodegenerative and neuropsychiatric indications, specifically, autism spectrum disorder.
read more
StemExpress now includes distribution partnerships with ATCG Limited, Kim & Friends, BIOTOOLS, Axil Scientific Pte and Custom Science.
read more
StemExpress is excited to announce that we will be opening our eighth facility with our newest location in Reno, Nevada.
read more
StemoniX announced the opening of its new, state-of-the-art research & development (R&D) facility in La Jolla, CA.
read more
Sterigenics announced it is building a new facility in Markham Vale North in Chesterfield/Derbyshire, UK.
read more